American International Group’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-81,481
| Closed | -$4.28M | – | 3188 |
|
|
2020
Q3 | $4.28M | Sell |
81,481
-1,887
| -2% | -$78.1K | 0.02% | 721 |
|
|
2020
Q2 | $2.77M | Buy |
83,368
+5,328
| +7% | +$170K | 0.01% | 856 |
|
|
2020
Q1 | $2.12M | Buy |
78,040
+5,462
| +8% | +$152K | 0.01% | 852 |
|
|
2019
Q4 | $1.43M | Sell |
72,578
-494
| -0.7% | -$7.9K | 0.01% | 1153 |
|
|
2019
Q3 | $947K | Sell |
73,072
-808
| -1% | -$9.76K | ﹤0.01% | 1315 |
|
|
2019
Q2 | $920K | Buy |
73,880
+170
| +0.2% | +$2.26K | ﹤0.01% | 1359 |
|
|
2019
Q1 | $1.07M | Buy |
73,710
+11,259
| +18% | +$144K | ﹤0.01% | 1283 |
|
|
2018
Q4 | $689K | Buy |
62,451
+2,003
| +3% | +$27.9K | ﹤0.01% | 1488 |
|
|
2018
Q3 | $1.59M | Buy |
60,448
+1,227
| +2% | +$33.2K | 0.01% | 1165 |
|
|
2018
Q2 | $1.21M | Buy |
59,221
+10,892
| +23% | +$234K | ﹤0.01% | 1265 |
|
|
2018
Q1 | $877K | Sell |
48,329
-11,873
| -20% | -$198K | ﹤0.01% | 1354 |
|
|
2017
Q4 | $840K | Buy |
60,202
+1,711
| +3% | +$23.1K | ﹤0.01% | 1469 |
|
|
2017
Q3 | $1.08M | Buy |
58,491
+4,357
| +8% | +$72.8K | ﹤0.01% | 1296 |
|
|
2017
Q2 | $915K | Buy |
54,134
+14,121
| +35% | +$215K | ﹤0.01% | 1342 |
|
|
2017
Q1 | $534K | Sell |
40,013
-7,446
| -16% | -$117K | ﹤0.01% | 1555 |
|
|
2016
Q4 | $714K | Sell |
47,459
-461
| -1% | -$6.09K | ﹤0.01% | 1426 |
|
|
2016
Q3 | $560K | Sell |
47,920
-147
| -0.3% | -$1.73K | ﹤0.01% | 1547 |
|
|
2016
Q2 | $519K | Buy |
48,067
+1,824
| +4% | +$18.8K | ﹤0.01% | 1566 |
|
|
2016
Q1 | $427K | Buy |
46,243
+2,042
| +5% | +$22K | ﹤0.01% | 2121 |
|
|
2015
Q4 | $656K | Buy |
44,201
+497
| +1% | +$8.32K | ﹤0.01% | 1812 |
|
|
2015
Q3 | $717K | Sell |
43,704
-117
| -0.3% | -$2.4K | ﹤0.01% | 1701 |
|
|
2015
Q2 | $1,000K | Buy |
43,821
+7,738
| +21% | +$154K | ﹤0.01% | 1583 |
|
|
2015
Q1 | $548K | Buy |
36,083
+439
| +1% | +$5.7K | ﹤0.01% | 2086 |
|
|
2014
Q4 | $429K | Sell |
35,644
-1,057
| -3% | -$12.1K | ﹤0.01% | 2281 |
|
|
2014
Q3 | $416K | Sell |
36,701
-298
| -0.8% | -$3.4K | ﹤0.01% | 2306 |
|
|
2014
Q2 | $447K | Sell |
36,999
-274
| -0.7% | -$3.24K | ﹤0.01% | 2272 |
|
|
2014
Q1 | $434K | Buy |
37,273
+1,499
| +4% | +$25.4K | ﹤0.01% | 2187 |
|
|
2013
Q4 | $632K | Buy |
35,774
+185
| +0.5% | +$3.11K | ﹤0.01% | 1843 |
|
|
2013
Q3 | $512K | Sell |
35,589
-578
| -2% | -$8.85K | ﹤0.01% | 1955 |
|
|
2013
Q2 | $545K | Buy |
+36,167
| New | +$477K | ﹤0.01% | 1787 |
|
American International Group's MNTA Position: Q4 2020 in Review
American International Group sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 81,481 shares — an estimated $4.28M sold.
American International Group first reported a position in MNTA in Q2 2013 and held it in 30 quarters. The position peaked at $4.28M in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.
- American International Group reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
- American International Group sold 81,481 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $4.28M.
- American International Group first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2013 and held it in 30 quarters.
- American International Group's Momenta Pharmaceuticals, Inc. position peaked at $4.28M in Q3 2020.
- 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.
Based on American International Group's 13F filing for Q4 2020, filed 12 Feb 2021.